[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100476631":3},{"organization":4,"outcomesModule":7,"designInfo":39,"detailedDescription":11,"studyPopulation":11,"armGroups":45,"interventions":51,"overallOfficials":57,"centralContacts":65,"locations":71,"responsibleParty":90,"collaborators":11,"id":92,"slug":11,"hasResults":93,"nctId":94,"briefTitle":95,"officialTitle":96,"acronym":11,"eligibilityCriteria":97,"healthyVolunteers":93,"sex":98,"minAge":99,"maxAge":100,"enrollmentInfo":101,"targetDuration":11,"studyType":104,"phases":105,"briefSummary":106,"conditions":107,"keywords":11,"overallStatus":74,"whyStopped":11,"lastUpdateSubmitDate":109,"lastUpdatePostDateStruct":110,"startDateStruct":113,"completionDateStruct":115,"leadSponsor":117,"locationsCount":118},{"fullName":5,"class":6},"Hospital St. Joseph, Marseille, France","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":11},[9],{"measure":10,"description":11,"timeFrame":12},"Positive Predictive Value (PPV)",null,"5 years",[14,16,18,20,22,25,27,29,31,34,36],{"measure":15,"description":11,"timeFrame":12},"Sensitivity",{"measure":17,"description":11,"timeFrame":12},"Specificity",{"measure":19,"description":11,"timeFrame":12},"Early stage lung cancer detection rate (stage I and II)",{"measure":21,"description":11,"timeFrame":12},"5-year survival rate of patients who have undergone thoracic surgery",{"measure":23,"description":24,"timeFrame":12},"Rate of smoking-related co-morbidities detected on low-dose CT scan","smoking-related co-morbities = pulmonary emphysema, interstitial lung disease, atheromatous disease, hepatic steatosis and ascending aortic aneurysm.",{"measure":26,"description":11,"timeFrame":12},"Rate of additional examinations (including invasive diagnostic tests and surgery with benign results)",{"measure":28,"description":11,"timeFrame":12},"Risk ratio of lung cancer",{"measure":30,"description":11,"timeFrame":12},"Number of false positive results",{"measure":32,"description":33,"timeFrame":12},"Penetration rate","number of subjects included \u002F number of includible subjects",{"measure":35,"description":11,"timeFrame":12},"Smoking cessation rates",{"measure":37,"description":38,"timeFrame":12},"EORTC QLQ-C30 score (version 3)","The EORTC Core Quality of Life questionnaire (EORTC QLQ-C30) is designed to measure cancer patients' physical, psychological and social functions.\n\nThe EORTC QLQ-C30 is composed of 9 multi-item scales: 5 functioning scales (physical, role, cognitive, emotional and social), a global QOL scale, and 3 symptom scales (fatigue, pain and nausea\u002Fvomiting). In addition, several single item symptom measures are used.\n\nFor the five functioning scales and the global quality of life scale, a higher score represents a better level of functioning. For the symptom scales and items, a high score corresponds to a higher level of symptomatology.",{"allocation":40,"interventionModel":41,"interventionModelDescription":11,"primaryPurpose":42,"observationalModel":11,"timePerspective":11,"maskingInfo":43},"NA","SINGLE_GROUP","DIAGNOSTIC",{"masking":44,"maskingDescription":11,"whoMasked":11},"NONE",[46],{"label":47,"type":48,"description":11,"interventionNames":49},"CT scan","EXPERIMENTAL",[50],"Diagnostic Test: Low-dose chest CT scan",[52],{"type":53,"name":54,"description":55,"armGroupLabels":56,"otherNames":11},"DIAGNOSTIC_TEST","Low-dose chest CT scan","baseline, 1-year, 3-year and 5-year low-dose CT scan",[47],[58,62],{"name":59,"affiliation":60,"role":61},"Arnaud Boyer, MD","Hopital Saint Joseph Marseille","PRINCIPAL_INVESTIGATOR",{"name":63,"affiliation":60,"role":64},"Illies Bouabdallah, MD","STUDY_DIRECTOR",[66],{"name":67,"role":68,"phone":69,"phoneExt":11,"email":70},"Cecile Bielmann","CONTACT","0033488731070","cbielman@hopital-saint-joseph.fr",[72],{"facility":73,"status":74,"city":75,"state":11,"zip":11,"country":76,"countryCode":77,"cosmosGeoPoint":78,"geoPoint":83,"contacts":84},"Hôpital Saint Joseph","RECRUITING","Marseille","France","FR",{"type":79,"coordinates":80},"Point",[81,82],5.38107,43.29695,{"lat":82,"lon":81},[85,88],{"name":86,"role":68,"phone":69,"phoneExt":11,"email":87},"Cécile BIELMANN","cbielmann@hopital-saint-joseph.fr",{"name":89,"role":61,"phone":11,"phoneExt":11,"email":11},"Arnaud Boyer",{"type":91,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR","100476631",false,"NCT05486455","Evaluation of Lung Cancer CT Screening Performance Among Former and Current Smokers","Evaluation of Lung Cancer CT Screening Performance Among Former and Current Smokers: a \"Real Life\" Study","Inclusion Criteria:\n\n* Male or female 50-80 years old\n* Active smoker (≥ 15 PA) or former smoker (≥ 15 PA)\n\nExclusion Criteria:\n\n* Recent history of chest CT scan (within 12 months)\n* Person unable to climb 2 floors\n* Weight \\> 140kg\n* Personal history of cancer \\\u003C 5 years (currently being monitored by thoracic imaging)","ALL","50 Years","80 Years",{"count":102,"type":103},1000,"ESTIMATED","INTERVENTIONAL",[40],"Diagnostic performance of low-dose chest CT scan combined with lung-RADS classification (version 1.1) for lung cancer screening among former and current smokers.",[108],"Smoking","2022-12-02",{"date":111,"type":112},"2022-12-06","ACTUAL",{"date":114,"type":112},"2022-11-04",{"date":116,"type":103},"2028-10",{"name":5,"class":6},1]